AngioDynamics, Inc. (ANGO) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
AngioDynamics, Inc. (ANGO) Bundle
Enhance your investment strategies with the AngioDynamics, Inc. (ANGO) DCF Calculator! Explore real financial data from AngioDynamics, adjust growth projections and expenses, and instantly visualize how these changes affect the intrinsic value of AngioDynamics, Inc. (ANGO).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 264.2 | 291.0 | 316.2 | 338.8 | 303.9 | 315.8 | 328.2 | 341.0 | 354.4 | 368.3 |
| Revenue Growth, % | 0 | 10.17 | 8.66 | 7.13 | -10.28 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 |
| EBITDA | -143.7 | -8.9 | 11.1 | 12.2 | -14.3 | -34.8 | -36.1 | -37.6 | -39.0 | -40.6 |
| EBITDA, % | -54.41 | -3.06 | 3.52 | 3.6 | -4.7 | -11.01 | -11.01 | -11.01 | -11.01 | -11.01 |
| Depreciation | 23.5 | 26.3 | 29.5 | 33.2 | 27.7 | 29.2 | 30.3 | 31.5 | 32.7 | 34.0 |
| Depreciation, % | 8.89 | 9.03 | 9.33 | 9.79 | 9.12 | 9.23 | 9.23 | 9.23 | 9.23 | 9.23 |
| EBIT | -167.2 | -35.2 | -18.4 | -21.0 | -42.0 | -63.9 | -66.4 | -69.0 | -71.7 | -74.6 |
| EBIT, % | -63.31 | -12.09 | -5.81 | -6.19 | -13.82 | -20.24 | -20.24 | -20.24 | -20.24 | -20.24 |
| Total Cash | 54.4 | 48.2 | 28.8 | 44.6 | 76.1 | 53.4 | 55.4 | 57.6 | 59.9 | 62.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 31.3 | 35.4 | 52.3 | 52.8 | 43.6 | 44.5 | 46.3 | 48.1 | 50.0 | 51.9 |
| Account Receivables, % | 11.84 | 12.17 | 16.54 | 15.59 | 14.35 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 |
| Inventories | 59.9 | 48.6 | 51.4 | 55.3 | 60.6 | 58.1 | 60.3 | 62.7 | 65.1 | 67.7 |
| Inventories, % | 22.68 | 16.71 | 16.25 | 16.33 | 19.95 | 18.38 | 18.38 | 18.38 | 18.38 | 18.38 |
| Accounts Payable | 19.1 | 19.6 | 28.0 | 40.4 | 37.8 | 29.8 | 31.0 | 32.2 | 33.5 | 34.8 |
| Accounts Payable, % | 7.23 | 6.75 | 8.87 | 11.94 | 12.42 | 9.44 | 9.44 | 9.44 | 9.44 | 9.44 |
| Capital Expenditure | -7.6 | -13.7 | -4.3 | -4.4 | -5.8 | -7.7 | -8.0 | -8.3 | -8.6 | -8.9 |
| Capital Expenditure, % | -2.87 | -4.71 | -1.36 | -1.28 | -1.9 | -2.42 | -2.42 | -2.42 | -2.42 | -2.42 |
| Tax Rate, % | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 |
| EBITAT | -165.9 | -30.8 | -16.3 | -20.2 | -40.4 | -59.8 | -62.2 | -64.6 | -67.1 | -69.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -222.0 | -10.5 | -2.3 | 16.6 | -17.2 | -44.6 | -42.7 | -44.3 | -46.1 | -47.9 |
| WACC, % | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -181.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -49 | |||||||||
| Terminal Value | -877 | |||||||||
| Present Terminal Value | -609 | |||||||||
| Enterprise Value | -790 | |||||||||
| Net Debt | -71 | |||||||||
| Equity Value | -719 | |||||||||
| Diluted Shares Outstanding, MM | 40 | |||||||||
| Equity Value Per Share | -17.90 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to create various scenarios.
- Real-World Data: AngioDynamics, Inc.'s (ANGO) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for testing projections, validating strategies, and saving time.
Key Features
- Comprehensive Financial Data: AngioDynamics' historical financial statements and pre-populated projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: View AngioDynamics' intrinsic value recalculated instantly.
- Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.
How It Works
- 1. Access the Template: Download and open the Excel file containing AngioDynamics, Inc.'s (ANGO) preloaded financial data.
- 2. Modify Key Inputs: Adjust essential parameters such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results Immediately: The DCF model automatically computes the intrinsic value and NPV based on your inputs.
- 4. Explore Different Scenarios: Evaluate various forecasts to understand potential valuation variations.
- 5. Present with Assurance: Deliver expert valuation insights to enhance your decision-making process.
Why Choose AngioDynamics, Inc. (ANGO) Solutions?
- Enhance Efficiency: Our tools streamline processes, eliminating the need for complex setups.
- Boost Precision: Access to accurate data and methodologies minimizes discrepancies in your assessments.
- Completely Adaptable: Modify our solutions to align with your specific needs and forecasts.
- User-Friendly: Intuitive interfaces and visualizations facilitate straightforward analysis of results.
- Endorsed by Professionals: Crafted for experts who prioritize accuracy and functionality.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling AngioDynamics, Inc. (ANGO) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for AngioDynamics, Inc. (ANGO).
- Consultants: Deliver professional valuation insights on AngioDynamics, Inc. (ANGO) to clients quickly and accurately.
- Business Owners: Understand how companies like AngioDynamics, Inc. (ANGO) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to AngioDynamics, Inc. (ANGO).
What the Template Contains
- Historical Data: Includes AngioDynamics, Inc.'s (ANGO) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate AngioDynamics, Inc.'s (ANGO) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of AngioDynamics, Inc.'s (ANGO) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.